J&J Launches Appeal Of $572M Okla. Opioid Judgment
Law360 (September 26, 2019, 9:44 PM EDT) -- Johnson & Johnson kicked off its promised appeal of a $572 million judgment in Oklahoma's first-in-the-nation trial over drugmaker liability for the opioid crisis, calling the ruling profoundly flawed and warning of "grave implications" for large swaths of the private sector.
In a pair of filings on Wednesday at the Oklahoma Supreme Court, J&J and its Janssen Pharmaceuticals Inc. arm started the appeal process with early insights into how the landmark decision in August by Oklahoma Judge Thad Balkman will be attacked.
The answer appeared to be this: in virtually every way imaginable and in the strongest terms possible.
According to J&J,...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!